Cardiac Resynchronisation Therapy is Cost Effective
2010
Conflicts of interests: Drs Freemantle and Cleland were members of the CARE-HF trial Steering Committee funded by Medtronic. All authors received funding to attend meetings and undertake work relating to the trial and authored the cost-effectiveness analyses. All authors have received honoraria for speaking at meetings and research funding from companies in the pharmaceutical and device industries.
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
14
References
1
Citations
NaN
KQI